Peripheral Artery Disease Market Size & Growth Forecast 2027–2036, By Segments (Device Type, Anatomical Site, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Device Type Segment Analysis: Endovascular Devices (Largest & Fastest-Growing Segment)

The endovascular devices segment accounted for the largest share of 63.26% in the 2026 peripheral artery disease market and is also expected to grow at the fastest pace during the forecast period. Its leading position is supported by the increasing use of minimally invasive approaches for restoring blood flow in patients with peripheral arterial disease. Endovascular procedures can provide clinicians with less invasive treatment options compared with open surgical interventions, while supporting shorter recovery periods and reduced procedural burden for appropriate patients. The expanding adoption of angioplasty-based interventions, stent technologies, atherectomy systems, and other catheter-based approaches is strengthening the role of endovascular devices across peripheral vascular treatment pathways. Continuous improvements in device design, deliverability, lesion crossing, and vessel treatment are further expanding their clinical utility. In addition, growing awareness of peripheral artery disease, increasing diagnosis of symptomatic patients, and the broader shift toward minimally invasive vascular interventions are supporting continued demand for endovascular devices.

Anatomical Site Segment Analysis: Femoropopliteal (Largest & Fastest-Growing Segment)

The femoropopliteal segment accounted for the largest share of 47.38% in the 2026 peripheral artery disease market and is also expected to grow at the fastest pace during the forecast period. The prominence of the femoropopliteal anatomical site is associated with the substantial clinical burden of disease affecting the superficial femoral and popliteal arteries and the complexity involved in treating lesions in this vascular region. These vessels are exposed to mechanical forces associated with movement of the lower extremities, creating challenges for maintaining long-term vessel patency and encouraging continued development of specialized treatment approaches. The growing adoption of endovascular interventions is increasing demand for technologies capable of navigating and treating lesions in the femoropopliteal region. Advances in drug-delivery technologies, stent platforms, atherectomy systems, and other interventional approaches are expanding treatment options for patients with complex lesions. Increasing diagnosis and treatment of peripheral artery disease, together with ongoing innovation focused on improving procedural outcomes, is expected to sustain strong demand for interventions targeting the femoropopliteal anatomical site.

End Use Segment Analysis: Hospitals (Largest Segment) vs Outpatient Facilities (Fastest-Growing Segment)

The hospitals segment accounted for the largest share of the 2026 peripheral artery disease market, reflecting the important role of hospital-based vascular services in diagnosing and treating patients with moderate to severe peripheral arterial disease. Hospitals provide access to specialized vascular teams, advanced imaging capabilities, catheterization facilities, surgical infrastructure, and emergency care, allowing complex peripheral vascular cases to be managed in an integrated clinical environment. The availability of multidisciplinary expertise is particularly important for patients requiring advanced endovascular procedures, surgical intervention, or management of multiple cardiovascular risk factors. Hospitals also benefit from established referral networks and the ability to manage patients across diagnosis, intervention, post-procedure monitoring, and follow-up. As awareness and diagnosis of peripheral artery disease increase and the demand for advanced vascular interventions continues to expand, hospitals are expected to remain an important setting for comprehensive disease management.

The outpatient facilities segment is expected to grow at the fastest pace during the forecast period, supported by the increasing adoption of minimally invasive peripheral vascular procedures and the broader shift toward lower-acuity care settings. Advances in endovascular devices and procedural techniques are enabling selected interventions to be performed with reduced recovery requirements, making outpatient treatment increasingly suitable for appropriate patients. Outpatient facilities can offer greater convenience, shorter stays, and potentially more efficient use of healthcare resources while maintaining access to specialized vascular procedures. Improvements in imaging, patient monitoring, anesthesia practices, and post-procedure care are further supporting the expansion of outpatient peripheral vascular services. As healthcare systems increasingly emphasize efficient care delivery and patients seek convenient treatment pathways, the growing suitability of minimally invasive peripheral artery disease procedures for outpatient management is expected to support continued expansion of this end-use segment.